These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9714023)

  • 1. Metabolic activity and clinical efficacy of animal and human hepatocytes in bioartificial support systems for acute liver failure.
    Riordan SM; Skouteris GG; Williams R
    Int J Artif Organs; 1998 Jun; 21(6):312-8. PubMed ID: 9714023
    [No Abstract]   [Full Text] [Related]  

  • 2. Artificial liver support devices for fulminant liver failure.
    Sechser A; Osorio J; Freise C; Osorio RW
    Clin Liver Dis; 2001 May; 5(2):415-30. PubMed ID: 11385970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of bioartificial liver support in acute liver failure.
    Hughes RD; Williams R
    Int J Artif Organs; 1996 Jan; 19(1):3-6. PubMed ID: 8641816
    [No Abstract]   [Full Text] [Related]  

  • 4. [Observation on hybrid bioartificial liver support systems in treating chronic severe hepatitis: a study of 60 cases].
    Luo HT; Liu QM; Tan JJ; Ye YN; Zhang PH; Luo ZD; Long H
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):205-9. PubMed ID: 16556417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term liver cell cultures in bioreactors and possible application for liver support.
    Gerlach JC
    Cell Biol Toxicol; 1997 Jul; 13(4-5):349-55. PubMed ID: 9298255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What should we expect from a bioartificial liver in fulminant hepatic failure?
    Bismuth H; Figueiro J; Samuel D
    Artif Organs; 1998 Jan; 22(1):26-31. PubMed ID: 9456223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular adsorbent recirculating system and bioartificial devices for liver failure.
    Bañares R; Catalina MV; Vaquero J
    Clin Liver Dis; 2014 Nov; 18(4):945-56. PubMed ID: 25438293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three different hepatocyte transplantation techniques for enzyme deficiency disease and acute hepatic failure.
    te Velde AA; Bosman DK; Oldenburg J; Sala M; Maas MA; Chamuleau RA
    Artif Organs; 1992 Oct; 16(5):522-6. PubMed ID: 10078305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bridging the gap: advances in artificial liver support.
    Nyberg SL
    Liver Transpl; 2012 Nov; 18 Suppl 2():S10-4. PubMed ID: 22767444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hybrid bioartificial liver for severe hepatitis].
    Duan ZP; Han DK; Liu Q; Zhao XY; Xue YL; Huang C; Zhao CH; Wang JT
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):305. PubMed ID: 12223150
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioartificial liver: its pros and cons.
    Chamuleau RA; Poyck PP; van de Kerkhove MP
    Ther Apher Dial; 2006 Apr; 10(2):168-74. PubMed ID: 16684219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bioartificial liver--state of the art.
    Strain AJ; Neuberger JM
    Science; 2002 Feb; 295(5557):1005-9. PubMed ID: 11834813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of bioartificial and artificial liver support devices.
    Hughes RD; Williams R
    Semin Liver Dis; 1996 Nov; 16(4):435-44. PubMed ID: 9027956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study.
    Roger V; Balladur P; Honiger J; Baudrimont M; Delelo R; Robert A; Calmus Y; Capeau J; Nordlinger B
    Ann Surg; 1998 Jul; 228(1):1-7. PubMed ID: 9671059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of artificial liver support in hepatic encephalopathy.
    Stadlbauer V; Wright GA; Jalan R
    Metab Brain Dis; 2009 Mar; 24(1):15-26. PubMed ID: 19101787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The promise of artificial liver replacement.
    Pryor HI; Vacanti JP
    Front Biosci; 2008 Jan; 13():2140-59. PubMed ID: 17981698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preliminary evaluation on the effects of a hybrid bioartificial liver support system in the treatment of hepatic failure].
    Wang YJ; He NH; Niu RZ; Liu J; Wen HW; Li JJ; Wang YM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):461-3. PubMed ID: 12939175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid bioartificial liver support in cynomolgus monkeys with D-galactosamine-induced acute liver failure.
    Zhang Z; Zhao YC; Cheng Y; Jian GD; Pan MX; Gao Y
    World J Gastroenterol; 2014 Dec; 20(46):17399-406. PubMed ID: 25516651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the extend of the culture time of primary hepatocytes in a bioreactor affect the treatment efficacy of a bioartificial liver?
    Flendrig LM; Maas MA; Daalhuisen J; Ladiges NC; La Soe JW; Te Velde AA; Chamuleau RA
    Int J Artif Organs; 1998 Sep; 21(9):542-7. PubMed ID: 9828060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive biochemical effects of a bioartificial liver support system (BALSS) in a porcine fulminant hepatic failure (FHF) model.
    Sheil AG; Sun J; Mears DC; Waring M; Woodman K; Johnston B; Horvat M; Watson J; Koutalistras N; Wang L
    Int J Artif Organs; 1998 Jan; 21(1):43-8. PubMed ID: 9554825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.